Der Urologe. Ausg. A

The most recent articles from: Urologe A June 2017

Der Urologe. Ausg. A · Jun 2017

Randomized Controlled Trial

[Nivolumab combined with ipilimumab versus sunitinib monotherapy-SUNNIFORECAST AN 41/16 of the AUO : A phase 2, randomized, open-label study in subjects with previously untreated and advanced (unresectable or metastatic) non-clear cell renal cell carcinoma].

no abstract available

read more… or not…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.